Special Issue "Research Advances in Percutaneous Coronary Intervention (PCI)"
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Clinical Medicine, Cell, and Organism Physiology".
Deadline for manuscript submissions: closed (25 June 2023) | Viewed by 206
Special Issue Editors
2. School of Medicine, The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China
3. School of Medicine, Guangdong Provincial People’s Hospital, South China University of Technology, Guangzhou, China
4. Department of Cardiology, Heyuan People’s Hospital, Heyuan, China
Interests: percutaneous coronary intervention; acute coronary syndrome; myocardial infarction; coronary heart disease; chronic total occlusion; intracoronary imaging; assessment of coronary stenosis
Interests: biostatistics; clinical trial design; randomized control trials; observational clinical studies; meta-analysis; network meta-analysis
Interests: percutaneous coronary intervention; acute coronary syndrome; myocardial infarction; heart failure; hypertension
Special Issue Information
Dear Colleagues,
Personalized medicine is the practice of tailoring medical treatment to the individual characteristics of each patient. Personalized medicine includes identifying patients most likely to benefit and those most likely to experience adverse reactions in response to a drug or therapy, and also tailoring therapy based on pharmacokinetics or pharmacodynamic response.
This Special Issue of the Journal of Personalized Medicine will highlight the current state of the art and showcase some of the latest findings in the field of percutaneous coronary intervention. This involves the evaluation of coronary function, including quantitative flow ratio, fractional flow reserves, etc., procedural guidance with intravascular ultrasound imaging, and optical coherence tomography, the treatment of left main or multivessel or bifurcation coronary artery disease, the use of drug-coated balloon and bioabsorbable stent, hemodynamic support devices for high-risk PCI, risk scoring systems for outcomes in PCI, antithrombotic therapy, as well as research on antithrombotic therapy.
Prof. Dr. Pengcheng He
Dr. Chongyang Duan
Dr. Yuanhui Liu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- percutaneous coronary intervention
- coronary function
- coronary artery disease
- antithrombotic therapy
